Chapter 629 Hearing Loss
Etiology
SNHL may be congenital or acquired. Acquired SNHL may be caused by genetic, infectious, autoimmune, anatomic, traumatic, ototoxic, and idiopathic factors (Tables 629-1, 629-2, 629-3, and 629-4). The recognized risk factors account for about 50% of cases of moderate to profound SNHL.
Table 629-1 INDICATORS ASSOCIATED WITH HEARING LOSS
INDICATORS ASSOCIATED WITH SENSORINEURAL AND/OR CONDUCTIVE HEARING LOSS
Neonates (Birth to 28 Days) When Universal Screening Is Not Available
Infants and Toddlers (Age 29 Days to 2 Yr) When Certain Health Conditions Develop that Require Rescreening
Infants and Toddlers (Age 29 Days to 3 Yr) Who Require Periodic Monitoring of Hearing
INDICATORS ASSOCIATED WITH DELAYED-ONSET SENSORINEURAL HEARING LOSS
INDICATORS ASSOCIATED WITH CONDUCTIVE HEARING LOSS
Note: At all ages, parents’ concern about hearing loss must be taken seriously even in the absence of risk factors.
ECMO, extracorporeal membrane oxygenation.
Adapted from American Academy of Pediatrics, Joint Committee on Infant Hearing: Joint Committee on Infant Hearing 1994 position statement, Pediatrics 95:152, 1995.
LOCUS | GENE | AUDIO PHENOTYPE |
---|---|---|
DFN3 | POU3F4 | Conductive hearing loss due to stapes fixation mimicking otosclerosis; superimposed progressive SNHL |
DFNA1 | DIAPH1 | Low-frequency loss beginning in the 1st decade and progressing to all frequencies to produce a flat audio profile with profound losses throughout the auditory range |
DFNA2 | KCNQ4 | Symmetrical high-frequency sensorineural loss beginning in the 1st decade and progressing over all frequencies |
GJB3 | Symmetrical high-frequency sensorineural loss beginning in the 3rd decade | |
DFNA 6/14/38 | WFS1 | Early-onset low-frequency sensorinerual loss; about 75% of families dominantly segregating this audio profile carry missense mutations in the C-terminal domain of wolframin. |
DFNA10 | EYA4 | Progressive loss beginning in the 2nd decade as a flat to gently sloping audio profile that becomes steeply sloping with age |
DFNA13 | COL11A2 | Congenital mid-frequency sensorineural loss that shows age-related progression across the auditory range |
DFNA15 | POU4F3 | Bilateral progressive sensorineural loss beginning in the 2nd decade |
DFNA20/26 | ACTG1 | Bilateral progressive sensorineural loss beginning in the 2nd decade; with age, the loss increases with threshold shifts in all frequencies, although a sloping configuration is maintained in most cases |
DFNB1 | GJB2, GJB6 | Hearing loss varies from mild to profound. The most common genotype, 35delG/35delG, is associated with severe to profound SNHL in about 90% of affected children; severe to profound deafness is observed in only 60% of children who are compound heterozygotes carrying 1 35delG allele and any other GJB2 SNHL-causing allele variant; in children carrying 2 GJB2 SNHL-causing missense mutations, severe to profound deafness is not observed. |
DFNB4 | SLC26A4 | DFNB4 and Pendred syndrome (see Table 629-3) are allelic. DFNB4 hearing loss is associated with dilatation of the vestibular aqueduct and can be unilateral or bilateral. In the high frequencies, the loss is severe to profound; in the low frequencies, the degree of loss varies widely. Onset can be congenital (prelingual), but progressive postlingual loss also is common. |
mtDNA 1555A > G | 12S rRNA | Degree of hearing loss varies from mild to profound but usually is symmetrical; high frequencies are preferentially affected; precipitous loss in hearing can occur after aminoglycoside therapy. |
From Smith RJH, Bale JF Jr, White KR: Sensorineural hearing loss in children, Lancet 365:879–890, 2005.
SNHL, sensorineural hearing loss.
SYNDROME | GENE | PHENOTYPE |
---|---|---|
DOMINANT | ||
Waardenberg (WS1) | PAX3 | Major diagnostic criteria include dystopia canthorum, congenital hearing loss, heterochromic irises, white forelock, and an affected first-degree relative. About 60% of affected children have congenital hearing loss; in 90%, the loss is bilateral. |
Waardenberg (WS2) | MITF, others | Major diagnostic criteria are as for WS1 but without dystopia canthorum. About 80% of affected children have congenital hearing loss; in 90%, the loss is bilateral. |
Branchio-otorenal | EYA1 | Diagnostic criteria include hearing loss (98%), preauricular pits (85%), and branchial (70%), renal (40%), and external-ear (30%) abnormalities. The hearing loss can be conductive, sensorineural, or mixed, and mild to profound in degree. |
RECESSIVE | ||
Pendred syndrome | SLC26A4 | Diagnostic criteria include sensorineural hearing loss that is congenital, nonprogressive, and severe to profound in many cases, but can be late-onset and progressive; bilateral dilation of the vestibular aqueduct with or without cochlear hypoplasia; and an abnormal perchlorate discharge test or goiter. |
Usher syndrome type 1 (USH1) | USH1A, MYO7A, USH1C, CDH23, USH1E, PCDH15, USH1G | Diagnostic criteria include congenital, bilateral, and profound hearing loss, vestibular areflexia, and retinitis pigmentosa (commonly not diagnosed until tunnel vision and nyctalopia become severe enough to be noticeable). |
Usher syndrome type 2 (USH2) | USH2A, USH2B, USH2C, others | Diagnostic criteria include mild to severe, congenital, bilateral hearing loss and retinitis pigmentosa; hearing loss may be perceived as progressing over time because speech perception decreases as diminishing vision interferes with subconscious lip reading. |
Usher syndrome type 3 (USH3) | USH3 | Diagnostic criteria include postlingual, progressive sensorineural hearing loss, late-onset retinitis pigmentosa, and variable impairment of vestibular function. |
From Smith RJH, Bale JF Jr, White KR: Sensorineural hearing loss in children, Lancet 365:879–890, 2005.
Table 629-4 INFECTIOUS PATHOGENS IMPLICATED IN SENSORINEURAL HEARING LOSS IN CHILDREN
CONGENITAL INFECTIONS
ACQUIRED INFECTIONS
From Smith RJH, Bale JF Jr, White KR: Sensorineural hearing loss in children, Lancet 365:879–890, 2005.
Infectious Causes
The most common infectious cause of congenital SNHL is cytomegalovirus (CMV), which infects 1/100 newborns in the USA (Chapters 247 and 630). Of these, 6,000-8,000 infants each year have clinical manifestations, including approximately 75% with SNHL. Congenital CMV warrants special attention because it is associated with hearing loss in its symptomatic and asymptomatic forms, and the hearing loss may be progressive. Some children with congenital CMV have suddenly lost residual hearing at 4-5 yr of age. Much less common congenital infectious causes of SNHL include toxoplasmosis and syphilis. Congenital CMV, toxoplasmosis, and syphilis also can manifest with delayed onset of SNHL months to years after birth. Rubella, once the most common viral cause of congenital SNHL, is very uncommon because of effective vaccination programs. In utero infection with herpes simplex virus is rare, and hearing loss is not an isolated manifestation.
Genetic Causes
Genetic causes of SNHL probably are responsible for as many as 50% of SNHL cases (see Tables 629-2 and 629-3). These disorders may be associated with other abnormalities, may be part of a named syndrome, or can exist in isolation. SNHL often occurs with abnormalities of the ear and eye and with disorders of the metabolic, musculoskeletal, integumentary, renal, and nervous systems.
Unlike children with an easily identified syndrome or with anomalies of the outer ear, who may be identified as being at risk for hearing loss and consequently monitored adequately, children with nonsyndromic hearing loss present greater diagnostic difficulty. Mutations of the connexin-26 and -30 genes have been identified in autosomal recessive (DNFB 1) and autosomal dominant (DNFA 3) SNHL and in sporadic patients with nonsyndromic SNHL; up to 50% of nonsyndromic SNHL may be related to a mutation of connexin-26. Mutations of the GJB2 gene co-localize with DFNA 3 and DFNB 1 loci on chromosome 13, are associated with autosomal nonsyndromic susceptibility to deafness, and are associated with as many as 30% of cases of sporadic severe to profound congenital deafness and 50% of cases of autosomal recessive nonsyndromic deafness. Sex-linked disorders associated with SNHL, thought to account for 1-2% of SNHL, include Norrie disease, the otopalatal digital syndrome, Nance deafness, and Alport syndrome. Chromosomal abnormalities such as trisomy 13-15, trisomy 18, and trisomy 21 also can be accompanied by hearing impairment. Patients with Turner syndrome have monosomy for all or part of 1 X chromosome and can have CHL, SNHL, or mixed hearing loss. The hearing loss may be progressive. Mitochondrial genetic abnormalities also can result in SNHL (see Table 629-2).